Obesity, endothelial function and inflammation: The effects of weight loss after bariatric surgery;Obesidad, inflamación y función endotelial: Efectos de la pérdida de peso tras cirugía bariatrica

Nutricion Hospitalaria

Volumn 33, Issue 6, 2016, Pages 1340-1346

  Illán Gómez, Fátima ^a   Gonzálvez Ortega, Manuel ^a   Aragón Alonso, Aurora ^a   Orea Soler, Isabel ^a   Alcaraz Tafalla, M Soledad ^a   Pérez Paredes, Matías ^a   Lozano Almela, M Luisa ^a  

^a HOSPITAL MORALES MESEGUER   (Spain)

Author keywords

Bariatric surgery; Endothelial activation; Inflammation; Insulin resistance; Obesity

Indexed keywords

BIOLOGICAL MARKER;

ADULT; BARIATRIC SURGERY; BLOOD; FEMALE; HUMAN; INFLAMMATION; INSULIN RESISTANCE; MALE; MIDDLE AGED; OBESITY; PATHOPHYSIOLOGY; VASCULAR ENDOTHELIUM; WEIGHT REDUCTION;

ADULT; BARIATRIC SURGERY; BIOMARKERS; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; INFLAMMATION; INSULIN RESISTANCE; MALE; MIDDLE AGED; OBESITY; WEIGHT LOSS;

EID: 85009794034     PISSN: 02121611     EISSN: 16995198     Source Type: Journal    
DOI: 10.20960/nh.793     Document Type: Article

References (54)

1. Yusuf S, Hawken S, Ounpuu S, Franzosi MG, Commeford P, Lang CC, et al. Obesity and the risk of myocardial infarction in 27000 participants from 52 countries: a case-control study. Lancet 2005;366:1640-9.
2. Wilson PW, D’ Agostino RB, Sullivan L, Parise H, Kannel WB. Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. Arch Intern Med 2002;162:1867-72.
3. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002;105:1135-43.
4. Ross R. Atherosclerosis, an inflammatory disease. N Engl J Med 1999;340:115-26.
5. Libby P. Changing concepts of atherogenesis. J Intern Med 2000;247:349-581.
6. Blankenberg S, Barbaux S, Tiret L. Adhesion molecules and atherosclerosis. Atherosclerosis 2003;170:191-203.
7. Vaughan DE. PAI-1 and atherothrombosis. J Thromb Haemost 2005;3:1879-83.
8. Ito H, Ohshima A, Inoue M, Ohto N, Nakasuga K, Kaji Y, et al. Weight reduction decreases soluble cellular adhesion molecules in obese women. Clin Exp Pharmacol Physiol 2002;29:399-404.
9. Straczkowski M, Lewczuk P, Dzienis-Straczkowska S, Kowalska I, Stepien A, Kinalska I. Elevated soluble intercellular adhesion molecular-1 levels in obesity: relationship to insulin resistance and tumor necrosis factor-alpha system activity. Metabolism 2002;51:75-8.
10. Steffen BT, Steffen LM, Tracy R, Siscovick D, Hanson NQ, Nettleton J, Tsai MI. Obesity modifies the association between plasma phospholipid polyunsaturated fatty acids and markers of inflammation: the Multi-Ethnic Study of Atherosclerosis. Int J Obes 2012;36:797-804.
11. Weyer C, Yudkin JS, Stehouwer CD, Schalkwijk CG, Pratley RE, Tataranni PA. Humoral markers of inflammation and endothelial dysfunction in relation adiposity and in vivo insulin action in Pima Indians. Atherosclerosis 2002;161:233-42.
12. Mertens I, Van Gaal LF. Obesity, haemostasis and the fibrinolytic system. Obesity Reviews 2002;3:85-101.
13. Skurk T, Hauner H. Obesity and impaired fibrinolysis: role of adipose production of plasminogen activator inhibitor-1. Int J Obes Relat Metab Disord 2004;28:1357-64.
14. Alessi MC, Juhan-Vague I. PAI-1 and the metabolic syndrome. Links, causes, and consequences. Arterioscler Thromb Vasc Bioln 2006;26:2200-7.
15. Ferri C, Desideri G, Valenti M, Bellini C, Pasin M, Santucci A, et al. Early upregulation of endothelial adhesion molecules in obese hypertensive men. Hypertension 1999;34:568-73.
16. Glowinska B, Urban M, Peczynska J, Florys B. Soluble adhesion molecules (sICAM-1, sVCAM-1) and selectins (sE selectin, sP selectin, sL selectin) levels in children and adolescents with obesity, hypertension, and diabetes. Metabolism Clinical and Experimental 2005;54:1020-6.
17. Kent JW, Comuzzie AG, Mahaney MC, Almasy L, Rainwater D, VandeBerg JL, et al. Intercellular adhesion molecule–1 concentration is genetically correlated with insulin resistance, obesity, and HDL concentration in Mexican Americans. Diabetes 2004;53:2691-5.
18. Vazquez LA, Pazos F, Berrazueta JR, Fernández-Escalante C, Garcia Unzueta MT, Freijanes J, et al. Effects of changes in body weight and insulin resistance on inflammation and endothelial function in morbid obesity after bariatric surgery. J Clin Endocrinol Metab 2005;90:316-22.
19. Nijhuis J, Van Dielen F, Fouraschen SMG, van den Broek MAJ, Rensen SSM, Buurman WA, et al. Endothelial activation markers and their key regulators after restrictive bariatric surgery Obesity 2007;15:1395-9.
20. Clifton PM, Keogh JB, Foste PR, Noakes M. Effect of weight loss on inflammatory and endothelial markers and FMD using two low-fat diets. Intl J Obes 2005;29:1445-51.
21. Van Dielen FMH, Buurman WA, Hadfoune M, Nijhuis J, Greve JW. Macrophage inhibitory factor, plasminogen activator inhibitor-1, other acute phase proteins, and inflammatory mediators normalize as a result of weight loss in morbidly obese subjects treated with gastric restrictive surgery. J Clin Endocrinol Metab 2004;89:4062-8.
22. Forsythe LK, Wallace JMW, Livingstone MBE. Obesity and inflammation: the effects of weight loss. Nutr Res Rev 2008;21:117-33.
23. Cottan DP, Mattar SG, Barinas Mitchell E, Eid G, Kuller L, Kelley DE, et al. The chronic inflammatory hypothesis for the morbidity associated with morbid obesity: implications and effects of weight loss. Obes Surg 2004;14:589-600.
24. Compher C, Badellino KO. Obesity and inflammation: lessons from bariatric surgery. JPEN 2008;32:645-7.
25. Shargorodsky M, Fleed A, Boaz M, Gavish D, Zimlichman R. The effect of a rapid weight loss induced by laparoscopic adjustable gastric banding on arterial stiffness, metabolic and inflammatory parameters in patients with morbid obesity. Int J Obes 2006;30:1632-8.
26. Vilarrasa N, Vendrell J, Sanchez-Santos R, Broch M, Megia A, Masdevall C, et al. Effect of weight loss induced by gastric bypass on proinflammatory interleukin-18, soluble tumour necrosis factor-α receptors, C-reactive protein and adiponectin in morbidly obese patients. Clin Endocrinol 2007;67:679-86.
27. Butner KL, Nickols-Richardson SM, Clark SF, Ramp WK, Herbert WG. A review of weight loss following Roux-en-Y gastric bypass vs restrictive bariatric surgery: impact on adiponectin and insulin. Obes Surg 2010;20:559-68.
28. Garcia de la Torre N, Rubio MA, Bordiú E, Cabrerizo L, Aparicio E, Hernández C, et al. Effects of weight loss after bariatric surgery for morbid obesity on vascular endothelial growth factor-A, adipocytokines, and insulin. J Clin Endocrinol Metab 2008;93:4276-81.
29. Holdstock C, Lind L, Eden Engstrom B, Ohrvall M, Sundbom M, Larsson A, et al. CRP reduction following gastric bypass surgery is most pronounced in insulin-sensitive subjects Int J Obes 2005;29:1275-80.
30. Trakhtenbroit MA, Leichman JG, Algahim MF, Miller CC, Moody FG, Lux TR, et al. Body weight, insulin resistance, and serum adipokine levels two years after two types of bariatric surgery. Am J Med 2009;122:435-42.
31. Swarbrick MM, Stanhope KL, Austrheim-Smith IT, Van Loan MD, Ali MR, Wolfe BM, et al. Longitudinal changes in pancreatic and adipocyte hormones following Roux-en-Y gastric bypass surgery. Diabetologia 2008;51:1901-11.
32. Capella RF, Capella JF. Reducing early technical complications in gastric by-pass surgery. Obes Surg 1997;7:149-57.
33. Ascaso JF, Pardo S, Real JT, Lorente RI, Priego A, Carmena R. Diagnosing insulin resistance by simple quantitative methods in subjects with normal glucose metabolism. Diabetes Care 2003;26:3320-5.
34. Dandona P, Aljada A, Bandyopadhyay A. Inflammation: the link between insulin resistance, obesity and diabetes. Trends Immunol 2004;25:4-7.
35. Libby P. Inflammation in atherosclerosis. Nature 2002;420:868-74.
36. Rajala MW, Scherer PE. Minireview: the adipocyte at the Cross roads of energy homeostasis, inflammation, and atherosclerosis. Endocrinology 2003;144:3765-73.
37. De Ferranti S, Mozaffarian D. The perfect storm: obesity, adipocyte dysfunction, and metabolic consequences. Clin Chem 2008;54:945-55.
38. Gregor MF, Hotamisligil GS Inflammatory Mechanisms in Obesity Annu Rev Immunol 2011;29:415-45.
39. Belza A, Toubro S, Stender S, Astrup A. Effect of diet-induced energy deficit and body fat reduction on high-sensitive CRP and other inflammatory markers in obese subjects. Int J Obes 2009;33:456-64.
40. Aljada A, Mohanty P, Ghanim H, Abdo T, Tripathy D, Chaudhuri A, et al. Increase in intranuclear nuclear factor κB and decrease in inhibitor κB inmononuclear cells after a mixed meal: evidence for a proinflammatory effect. Am J Clin Nutr 2004;79:682-90.
41. Dalmas E, Rouault C, Abdennour M, Rovere C, Rizkalla S, Bar-Hen A et al. Variations in circulating inflammatory factors are related to changes in calorie and carbohydrate intakes early in the course of surgery-induced weight reduction Am J Clin Nutr 2011;94:450-8.
42. Devaraj S, Kasim-karakas S, Jialil I. The effect of weight loss and dietary fatty acids on inflammation. Curr Atheroscler Rep 2006;8:477-86.
43. Clifton PM. Diet and C-reactive protein. Curr Atheroscler Rep 2003;5:431-6.
44. Ridker PM, Hennekens CH, Roitman-Johnson B, Stampfer MJ, Allen J. Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men. Lancet 1998;10:351:88-92.
45. Ziccardi P, Nappo F, Giugliano G, Esposito K, Marfella R, Cioffi M, et al. Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year. Circulation 2002;105:804-9.
46. Von der Thusen, Kuiper J, van Berkel TJC, Biessen EAL. Interleukins in atherosclerosis: molecular pathways and therapeutic potential. Pharmacol Rev 2003;55:133-66.
47. Romano M, Sironi M, Toniatti C, Polentarutti N, Fruscella P, Ghezzi P, et al. Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment. Immunity 1997;6:315-25.
48. Pasceri V, Willerson JT, Yeh ET. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 2000;102:2165-8.
49. Valle M, Martos R, Morales RM, Cañete R, Gascón F, Bermudo F. Endothelial dysfunction is related to insulin resistance and inflammatory biomarker levels in obese prepubertal children. Eur J Endocrinol 2007;156:497-502.
50. Saksela O, Rifkin DB. Cell-associated plasminogen activation/ regulation and physiological functions. Annu Rev Cell Biol 1988;4:93-126.
51. Ridker PM, Brown NJ, Vaughan DE, Harrison DG, Mehta JL. Established and emerging plasma biomarkers in the prediction of first atherothrombotic events. Circulation 2004;109:IV-6-IV-19.
52. Mertens I, Verrijken A, Michiels JJ, Van der Planken M, Ruige JB, Van Gaal LF. Among inflammation and coagulation markers, PAI-1 is a true component of the metabolic syndrome Int J Obes 2006;30:1308-14.
53. Devaraj S, Xu DY, Jialal I. C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells: implications for the metabolic syndrome and atherothrombosis. Circulation 2003;107:398-404.
54. Leinonen E, Hurt-Camejo E, Wiklund O, Hulten LM, Hiukka A, Taskinen MR. Insulin resistance and adiposity correlate with acute-phase reaction and soluble cell adhesion molecules in type 2 diabetes. Atherosclerosis 2003;166 387-94.